David Baltimore

David Baltimore was the founder of Helixis, Inc. founded in 2007, Calimmune, Inc. founded in 2006 where the title held was Director since 2015, Appia Bio, Inc. founded in 2020, and Immune Design Corp.
founded in 1997 where the title held was Independent Director from 2014 to 2019.
Current jobs include Vice Chairman at The Damon Runyon Cancer Research Foundation, Director at FasterCures, Director at The Broad Institute, Inc., Director at Foundation for Biomedical Research, Independent Director at Altos Labs, Inc., Trustee at The Jackson Laboratory, Science Partner at The Column Group LLC, and Member at Human Genome Organisation.
Former jobs include Vice Chairman at BB Biotech AG from 2010, Chairman at MPM BioImpact LLC, Chairman & President at American Association for the Advancement of Science from 2007 to 2009, Independent Director at Amgen, Inc. from 2011 to 2018, Director at MedImmune LLC from 2003 to 2007, Director & Member at Whitehead Institute for Biomedical Research, Independent Director at Regulus Therapeutics, Inc. from 2009 to 2025, Director at The Eli & Edythe Broad L.
Foundation, Professor at Massachusetts Institute of Technology from 1972 to 1997, President-Emeritus & Professor-Biology at California Institute of Technology from 1997 to 2006, Professor at The Rockefeller University from 1991 to 1994, Professor at American Cancer Society California Division, Inc. in 1983, and President at Caltech Industries, Inc. from 1997 to 2006.
Education includes undergraduate degree from Swarthmore College and doctorate from The Rockefeller University.